Singapore markets open in 8 hours 53 minutes

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.1999+0.1099 (+5.26%)
As of 11:37AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
817
743
810
853
763
Operating expenses
Research development
8,410
5,983
7,763
9,850
11,951
Selling general and administrative
3,448
2,955
3,143
3,845
2,951
Total operating expenses
11,858
8,938
10,906
13,695
14,902
Operating income or loss
-11,041
-8,195
-10,096
-12,842
-14,139
Interest expense
-
-
-
-
363
Total other income/expenses net
69
69
-283
221
38
Income before tax
-11,272
-7,634
-10,173
-12,615
-14,443
Income tax expense
0
0
0
0
0
Income from continuing operations
-11,272
-7,634
-10,173
-12,615
-14,443
Net income
-11,272
-7,634
-10,173
-12,615
-14,443
Net income available to common shareholders
-13,862
-7,634
-10,173
-15,205
-15,158
Basic EPS
-1.48
-
-3.00
-9.00
-12.00
Diluted EPS
-1.48
-
-3.00
-9.00
-12.00
Basic average shares
3,704
-
2,719
1,844
1,195
Diluted average shares
3,704
-
2,719
1,844
1,195